Form 8-K - Current report:
SEC Accession No. 0001213900-25-033505
Filing Date
2025-04-21
Accepted
2025-04-21 09:15:01
Documents
13
Period of Report
2025-04-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0238939-8k_enzobio.htm   iXBRL 8-K 20853
  Complete submission text file 0001213900-25-033505.txt   189158

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE enz-20250421.xsd EX-101.SCH 2999
3 XBRL LABEL FILE enz-20250421_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE enz-20250421_pre.xml EX-101.PRE 22349
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0238939-8k_enzobio_htm.xml XML 3450
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 25851428
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)